MedPath

University of Alberta

University of Alberta logo
🇨🇦Canada
Ownership
Private
Established
1908-01-01
Employees
10K
Market Cap
-
Website
http://www.ualberta.ca

Intravenous Fluid for Pediatric Migraine in the Emergency Department

Phase 1
Completed
Conditions
Migraine
Headache
Interventions
Drug: Normal saline
First Posted Date
2010-02-23
Last Posted Date
2016-11-06
Lead Sponsor
University of Alberta
Target Recruit Count
46
Registration Number
NCT01073787
Locations
🇨🇦

Stollery Children's Hospital Emergency Department, Edmonton, Alberta, Canada

The Effect of Probiotics (VSL) on Portal Hypertension

Phase 1
Completed
Conditions
Portal Hypertension
Interventions
First Posted Date
2009-12-16
Last Posted Date
2012-01-20
Lead Sponsor
University of Alberta
Target Recruit Count
18
Registration Number
NCT01032941
Locations
🇨🇦

University of Alberta, Edmonton, Alberta, Canada

Gastric Procedures for Obesity

Completed
Conditions
Morbid Obesity
First Posted Date
2009-12-04
Last Posted Date
2017-10-03
Lead Sponsor
University of Alberta
Target Recruit Count
150
Registration Number
NCT01026181

Evaluation of the Safety and Effectiveness of Stomaphyx for Transoral Incisionless Reduction of the Enlarged Gastric Pouch and Stoma

Phase 2
Completed
Conditions
Morbid Obesity
Interventions
Device: StomaphyX
First Posted Date
2009-12-03
Last Posted Date
2017-03-10
Lead Sponsor
University of Alberta
Target Recruit Count
14
Registration Number
NCT01025076
Locations
🇨🇦

CAMIS, Royal Alexandra Hospital, Edmonton, Alberta, Canada

Evaluation of the Safety and Effectiveness of Tailored Transoral Incisionless Fundoplication (TIF) Using EsophyX for the Treatment of GERD

Phase 2
Withdrawn
Conditions
Gastroesophageal Reflux Disease (GERD)
First Posted Date
2009-12-03
Last Posted Date
2015-04-29
Lead Sponsor
University of Alberta
Registration Number
NCT01025739
Locations
🇨🇦

CAMIS, Royal Alexandra Hospital, Edmonton, Alberta, Canada

Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research

Phase 1
Conditions
Breast Cancer
Heart Failure
Interventions
First Posted Date
2009-11-20
Last Posted Date
2016-02-09
Lead Sponsor
University of Alberta
Target Recruit Count
99
Registration Number
NCT01016886
Locations
🇨🇦

University of Alberta/ Cross Cancer Institute, Edmonton, Alberta, Canada

Effect of Gastric Bypass on the Absorption of Metformin

Completed
Conditions
Obesity
Gastric Bypass
First Posted Date
2009-11-13
Last Posted Date
2011-03-03
Lead Sponsor
University of Alberta
Target Recruit Count
34
Registration Number
NCT01013051
Locations
🇨🇦

University of Alberta Hospital Clinical Investigation Unity, Edmonton, Alberta, Canada

Confocal Endomicroscopy During Endoscopy

Completed
Conditions
Inflammatory Bowel Disease
Interventions
Device: Confocal endomicroscopy
First Posted Date
2009-10-02
Last Posted Date
2018-10-16
Lead Sponsor
University of Alberta
Target Recruit Count
220
Registration Number
NCT00988273
Locations
🇨🇦

University of Alberta, Edmonton, Alberta, Canada

Furosemide in Early Acute Kidney Injury

Phase 2
Terminated
Conditions
Acute Renal Failure
Interventions
Drug: Normal Saline
First Posted Date
2009-09-16
Last Posted Date
2015-09-30
Lead Sponsor
University of Alberta
Target Recruit Count
72
Registration Number
NCT00978354
Locations
🇦🇺

Austin Hospital, Melbourne, Victoria, Australia

🇦🇺

Princess Alexandra Hospital, Brisbane, Queensland, Australia

🇨🇦

University of Laval, Quebec City, Quebec, Canada

and more 1 locations

Effectiveness and Safety of Spondylitis Related to Inflammatory Bowel Disease

Phase 4
Withdrawn
Conditions
Crohn's Disease
Spondyloarthritis
Interventions
Biological: Adalimumab
First Posted Date
2009-09-04
Last Posted Date
2016-09-16
Lead Sponsor
University of Alberta
Registration Number
NCT00972218
Locations
🇨🇦

University of Alberta, Edmonton, Alberta, Canada

© Copyright 2025. All Rights Reserved by MedPath